Navigation Links
SeQual Technologies is Awarded the U.S. Army Airworthiness Certification

SAN DIEGO, Jan. 22 /PRNewswire/ -- SeQual Technologies Inc., a medical equipment manufacturer which develops oxygen systems known worldwide for their reliability, quality, and revolutionary design and economy, announces they have received the Airworthiness Release (AWR) from the U.S. Army's Research, Development, and Engineering Command for the Eclipse Oxygen Concentrator 1000A. The certification indicates that the Eclipse(R) Oxygen Concentrator 1000A is in compliance with the U.S. Department of Defense medical device certification criteria and is now certified for use aboard MEDEVAC H-60 Black Hawk helicopters.

The U.S. Army's Aeromedical Research Laboratory does extensive aeromedical testing that includes electromagnetic interference and compatibility, environmental and human factors testing in the laboratory as well as in-flight assessments by engineers and medical per-sonnel under a variety of flight conditions.

"Supporting our military with a first class product is an honor. Our mission is to offer the most reliable oxygen generating system that soldiers can depend on in the most extreme situations," says Pam Jackson, Senior Director of SeQual Technologies. "With the Eclipse HT receiving the Airworthiness Certification, medical grade oxygen can now be delivered during all phases of patient transport with substantial simplification and safety."

The Eclipse Oxygen Concentrator 1000A offers immediate, robust, dependable oxygen delivery and supports individual patients far forward on the battlefield and during medial evacuation missions. It is a small, lightweight point-of-use generator that can be moved with the patient which produces 93% +/- 3 medical grade oxygen and powered by AC/DC or battery. The system eliminates the safety hazards of pressurized oxygen and logistical burden of continual resupply of oxygen cylinders.

About the Eclipse HT

The Eclipse HT, is a battery operated oxygen generation system that offers 3 LPM of continuous-flow and pulse-dose setting up to six. This rugged, light-weight oxygen system can operate in extreme environmental conditions anywhere in the world. It is currently used in combat casualty care and is Airworthiness certified for H-60 helicopters.

About SeQual Technologies Inc.

Founded in 1991, SeQual offers a family of innovative products ranging from the 3 LPM (liter-per-minute) continuous flow portable Eclipse to its popular, compact, easy-to-use bedside 10 LPM unit. SeQual's air separation systems are used for industrial applications such as water purification, oxygenation for aquaculture, producing feed gas for ozone generators, or for any other processes needing high-purity, dry oxygen or nitrogen on site. SeQual is a private company based in San Diego.

For more information, see

SOURCE SeQual Technologies Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride
2. US Army Purchases SeQuals Cutting-Edge Oxygen Generation Technology for MRAP Deployment
3. San Diegos SeQual Technologies Loans 35 Portable Oxygen Units to Evacuees at Qualcomm Stadium
4. Enlight Biosciences Expands to direct up to $52 Million to Transformational Enabling Technologies
5. China Medical Technologies Announces the Receipt of SFDA Approval for Two of its FISH Probes and the Approval for the Hi-Tech Enterprise Status for its PRC Subsidiaries
6. VirtualHealth Technologies, Inc. Unveils Strategy to Leverage $20 Billion Federal Health IT Proposal
7. Deep Web Technologies Mednar Is Rated the #1 Alternative Health Search Engine
8. Global Med Technologies(R) Inlog Subsidiary Licensed EdgeTrack to 62 French Hospitals in 2008, Including 19 Hospitals in Q4 2008
9. Houstons NuPhysicia LLC has Remote Medical Technologies and Services Featured on CNN Health Report
10. Allen Technologies, Inc. Announces Vigo Interactive Communication and Education System Agreement with Saint John's Health Center, Santa Monica, California
11. InSet Technologies Completes $25 Million Financing
Post Your Comments:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: